Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response
10.5966/sctm.2013-0070
Saved in:
Main Authors: | Zeng, J., Wang, S. |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/100846 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Natural killer cell engineering for cellular therapy of cancer
by: Shook, D.R., et al.
Published: (2016) -
STEM CELL- AND DENDRITIC CELL-BASED CANCER IMMUNOTHERAPY TARGETING CANCER STEM CELLS
by: CHEN CAN
Published: (2015) -
CELL-BASED CANCER IMMUNOTHERAPY: FROM ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO DENDRITIC CELLS THERAPEUTIC VACCINATION
by: TAN WEE KIAT
Published: (2016) -
CHARACTERISATION OF THE ANTI-VIRAL T-CELL RESPONSE INDUCED BY HUMAN CD137 LIGAND DENDRITIC CELLS
by: ZULKARNAIN HARFUDDIN
Published: (2014) -
CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells
by: Cao, W., et al.
Published: (2011)